Diabetes and complications (diabetic ketoacidosis, diabetic nephropathy, diabetic peripheral neuropathy, diabetic retinopathy, etc.), regulation of gut microbiota in diabetes, reversal of diabetes, thyroid diseases (hyperthyroidism, hypothyroidism, subacute thyroiditis, thyroid nodules), pituitary diseases (prolactinoma, hypopituitarism), adrenal diseases, metabolic diseases (hyperlipidemia, hyperuricemia, gout), osteoporosis, obesity weight management, etc.

1. Clinical value of non-invasive methods in classifying primary aldosteronism [J]. Chinese Journal of Practical Internal Medicine, 2015, 35(07):631-633.

2. Predicting postoperative blood pressure outcomes in primary aldosteronism: Fisher discriminant model [J]. National Medical Journal of China, 2016, 96(42):3379-3383.

3. Current status and reflection on the application of clinical pathways in diabetic foot management [J]. Chinese Journal of Diabetes, 2017, 9(04):267-269.

Over 10 years of clinical experience in endocrinology; published several national-level medical papers.

Guangdong Medical Education Association, Grassroots Prevention and Treatment of Metabolic Diseases Committee / Member;

Guangdong Nutrition Society, Gut Microbiota and Nutritional Health Committee / Member;

Shenzhen Women Physicians Association, Second Endocrinology and Metabolic Diseases Committee / Member;

Shenzhen Guangming District Physicians Association, Endocrinology and Metabolic Diseases Committee / Member